NasdaqCM - Nasdaq Real Time Price USD

Vivani Medical, Inc. (VANI)

Compare
1.1300
-0.0100
(-0.88%)
At close: February 12 at 4:00:01 PM EST
1.1300
0.00
(0.00%)
Pre-Market: 8:43:33 AM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Adam Mendelsohn Ph.D. Co-Founder, CEO & Director 609.62k -- 1982
Mr. Truc Le M.B.A. Chief Operations Officer 486.3k -- 1953
Dr. Lisa E. Porter M.D. Chief Medical Officer 482.13k -- 1964
Mr. Donald Dwyer M.B.A. Chief Business Officer & Corporate Secretary 190.97k -- 1959

Vivani Medical, Inc.

1350 South Loop Road
Alameda, CA 94502
United States
415 506 8462 https://www.vivani.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
36

Description

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.

Corporate Governance

Vivani Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

November 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 26, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 4, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 13, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 11, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 28, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 13, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers